SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2
Description
Frequent mutation and variable immunological protection against vaccination is a common feature for COVID-19 pandemic. Early detection and confinement remain key to controlling further spread of infection. In response, we have developed an aptamer
